To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TBC1D14TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
502 supporting clones for gene TBC1D14 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_020773.2   TBC1D14.a 1 to 5008 2 to 5009 exact RefSeq,   5009/5009
(100 %)
0 diff
(100 %id)
DA754761   TBC1D14.a 1 to 444 2 to 445   tiling clone, capped   444/444
(100 %)
1 diff
(99.8 %id)
BQ213094 melanotic melanoma, skin TBC1D14.a 18 to 864 1 to 858       858/869
(98 %)
31 diff
(96.5 %id)
CN358109 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.a 25 to 775 1 to 751       751/751
(100 %)
1 diff
(99.9 %id)
DB088778 testis TBC1D14.a 32 to 574 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA215967 brain TBC1D14.a 35 to 327 2 to 294   capped   293/293
(100 %)
0 diff
(100 %id)
DA324755 hippocampus TBC1D14.a 35 to 575 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB063682 testis TBC1D14.a 35 to 546 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
BG427276 Kidney TBC1D14.a 49 to 792 1 to 745       745/745
(100 %)
16 diff
(97.9 %id)
CN358123 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 TBC1D14.a 50 to 522 20 to 492       473/492
(96 %)
6 diff
(98.8 %id)
CB960207 Human Placenta, placenta TBC1D14.a 58 to 733 28 to 705       678/770
(88 %)
9 diff
(98.9 %id)
DR005881 Prostate TBC1D14.a 66 to 494 1 to 429       429/429
(100 %)
5 diff
(98.9 %id)
BM475560 embryonal carcinoma, cell line, testis TBC1D14.a 68 to 784 5 to 732       728/1096
(66 %)
34 diff
(96.9 %id)
BG389314.
matches multiple genes
embryonal carcinoma, cell line, testis, Testis, embryonal carcinoma TBC1D14.a 70 to 672 1 to 614   available from MGC, also hits gene MST4 614/614
(100 %)
27 diff
(95.7 %id)
BU175400 embryonal carcinoma, cell line, testis TBC1D14.a 72 to 884 1 to 818       818/873
(93 %)
16 diff
(98.2 %id)
BC041167 Testis, embryonal carcinoma TBC1D14.a 77 to 5001 1 to 4924 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 4924/4924
(100 %)
4 diff
(100.0 %id)
DB457787.
matches multiple genes
testis TBC1D14.a 109 to 614 1 to 505     also hits gene LOC100129931 505/505
(100 %)
3 diff
(99.5 %id)
DA326671 hippocampus TBC1D14.a 111 to 654 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DR002019 fetal brain TBC1D14.a 123 to 761 7 to 645       639/645
(99 %)
6 diff
(99.1 %id)
DA314114 hippocampus TBC1D14.a 146 to 701 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB234542 trachea TBC1D14.b 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
NM_001113361.1   TBC1D14.b 202 to 5088 1 to 4887 exact RefSeq,   4887/4887
(100 %)
0 diff
(100 %id)
DA492919 brain TBC1D14.b 203 to 662 2 to 462   capped   461/461
(100 %)
1 diff
(99.8 %id)
DA317176 hippocampus TBC1D14.b 216 to 767 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA313071 hippocampus TBC1D14.b 225 to 756 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA859248 placenta TBC1D14.b 225 to 787 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB215182 trachea TBC1D14.b 225 to 766 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA724321   TBC1D14.b 226 to 697 2 to 476   capped   475/487
(97 %)
6 diff
(98.8 %id)
BP871980 embryonal kidney TBC1D14.b 227 to 807 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
DA776619 brain TBC1D14.b 227 to 813 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA225329 brain TBC1D14.b 232 to 798 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA311588 hippocampus TBC1D14.b 232 to 800 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA314091 hippocampus TBC1D14.b 232 to 790 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA317484 hippocampus TBC1D14.b 232 to 789 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA414127 thalamus TBC1D14.b 232 to 787 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA725749   TBC1D14.b 232 to 777 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BG388660 embryonal carcinoma, cell line, testis TBC1D14.b 246 to 991 1 to 747       747/803
(93 %)
25 diff
(96.9 %id)
EC584959 Prostate TBC1D14.b 260 to 368 9 to 117       109/117
(93 %)
6 diff
(94.9 %id)
AB037743 brain TBC1D14.b 262 to 5083 11 to 4832 L41V tiling clone, available from KIAA,   4822/4832
(99 %)
7 diff
(99.9 %id)
AB449900 brain TBC1D14.b 281 to 2362 1 to 2082 L41V     2082/2082
(100 %)
1 diff
(100.0 %id)
CN358117 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 TBC1D14.b 283 to 769 1 to 487       487/487
(100 %)
0 diff
(100 %id)
TI_1948210070   TBC1D14.b 319 to 1124 121 to 927       807/1268
(63 %)
17 diff
(98.7 %id)
TI_1948210285   TBC1D14.b 319 to 1124 122 to 930       809/1289
(62 %)
22 diff
(98.3 %id)
TI_1948210497   TBC1D14.b 319 to 1121 122 to 934       813/1348
(60 %)
22 diff
(98.4 %id)
TI_1948210722   TBC1D14.b 319 to 1116 125 to 924       800/1366
(58 %)
27 diff
(98.1 %id)
EL734381 mixed TBC1D14.b 326 to 997 1 to 668       668/668
(100 %)
4 diff
(99.5 %id)
CN358107 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TBC1D14.b 383 to 906 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
DA735909   TBC1D14.b 383 to 1124 2 to 743   capped   742/793
(93 %)
6 diff
(99.3 %id)
BI048158 stomach TBC1D14.b 724 to 1096 370 to 2       369/370
(99 %)
3 diff
(99.2 %id)
DA234421 brain TBC1D14.b 847 to 1428 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BF818715 colon_ins TBC1D14.b 913 to 1114 207 to 7     Submitted on the opposite strand 201/211
(95 %)
1 diff
(99.6 %id)
DA218143 brain TBC1D14.b 940 to 1482 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BG910318 anaplastic oligodendroglioma with 1p/19qloss, brain TBC1D14.b 956 to 1770 1 to 814       814/817
(99 %)
11 diff
(98.7 %id)
BM543053 embryonal carcinoma, cell line, testis TBC1D14.b 1006 to 1930 1 to 929       929/1053
(88 %)
22 diff
(98.0 %id)
BF948085 nervous_normal TBC1D14.b 1113 to 1446 12 to 345       334/353
(94 %)
14 diff
(96.1 %id)
BQ069122 brain, neuroblastoma, cell line TBC1D14.b 1143 to 1727 1 to 588       588/1379
(42 %)
7 diff
(99.5 %id)
BQ894090 brain, neuroblastoma, cell line TBC1D14.b 1143 to 2038 1 to 901       901/923
(97 %)
15 diff
(98.4 %id)
CN358116 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TBC1D14.b 1176 to 1722 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BF365855 nervous_tumor TBC1D14.b 1195 to 1445 1 to 251       251/262
(95 %)
2 diff
(99.3 %id)
AL833868 testis TBC1D14.b 1215 to 5083 1 to 3869   available from DKFZ, AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 3869/3869
(100 %)
3 diff
(100.0 %id)
AW503868 lymph TBC1D14.b 1220 to 1645 1 to 426       426/426
(100 %)
5 diff
(98.9 %id)
TI_154159900   TBC1D14.b 1227 to 1910 80 to 759       680/682
(99 %)
22 diff
(96.8 %id)
AA299989 uterus TBC1D14.b 1232 to 1476 1 to 245     Submitted on the opposite strand 245/245
(100 %)
0 diff
(100 %id)
DA778152 brain TBC1D14.b 1244 to 1815 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA726755   TBC1D14.b 1257 to 1814 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BF372631 prostate_tumor TBC1D14.b 1271 to 1621 369 to 19       351/370
(94 %)
4 diff
(99.0 %id)
BF354600 head_neck TBC1D14.b 1338 to 1504 168 to 1       168/186
(90 %)
4 diff
(97.9 %id)
DA098510 cerebellum TBC1D14.b 1430 to 1995 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
TI_1948210724   TBC1D14.b 1440 to 2361 1047 to 125       923/1368
(67 %)
24 diff
(98.3 %id)
TI_1948210498   TBC1D14.b 1441 to 2361 1048 to 127       922/1383
(66 %)
11 diff
(99.3 %id)
TI_1948210723   TBC1D14.b 1441 to 2361 1047 to 126       922/1420
(64 %)
18 diff
(98.8 %id)
TI_1948210071   TBC1D14.b 1442 to 2361 1047 to 127       921/1416
(65 %)
24 diff
(98.4 %id)
TI_1948210286   TBC1D14.b 1447 to 2361 1041 to 126       916/1378
(66 %)
19 diff
(98.7 %id)
TI_1948210499   TBC1D14.b 1447 to 2361 1036 to 127       910/1352
(67 %)
28 diff
(98.0 %id)
DA493426 brain TBC1D14.b 1471 to 2014 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DA100530 cerebellum TBC1D14.b 1496 to 2082 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA772473 brain TBC1D14.b 1539 to 2094 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA249738 brain TBC1D14.b 1540 to 2112 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
TI_1948210072   TBC1D14.b 1540 to 2361 948 to 130       819/1344
(60 %)
29 diff
(97.9 %id)
TI_1948210287   TBC1D14.b 1542 to 2361 939 to 129       811/1322
(61 %)
13 diff
(99.1 %id)
DB163457 thymus TBC1D14.b 1542 to 2098 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA239897 brain TBC1D14.b 1550 to 2134 10 to 595   capped   586/594
(98 %)
7 diff
(98.9 %id)
BG479167 choriocarcinoma, placenta TBC1D14.b 1673 to 2454 1 to 788       788/789
(99 %)
29 diff
(96.4 %id)
AA300225 uterus TBC1D14.b 1714 to 1908 1 to 195       195/301
(64 %)
5 diff
(98.4 %id)
TI_154167601   TBC1D14.b 1716 to 2197 80 to 562       483/484
(99 %)
28 diff
(94.3 %id)
TI_154117488   TBC1D14.b 1731 to 2687 1028 to 89   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 940/962
(97 %)
32 diff
(96.7 %id)
DA790587 brain TBC1D14.b 1745 to 2220 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA510641 brain TBC1D14.b 1748 to 2314 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BQ720193 sympathetic trunk TBC1D14.b 1758 to 2488 1 to 737       737/985
(74 %)
11 diff
(98.9 %id)
AI659483 Prostate TBC1D14.b 1761 to 2499 737 to 1       737/742
(99 %)
10 diff
(98.7 %id)
BE892583 melanotic melanoma, skin TBC1D14.b 1782 to 2390 1 to 608       608/609
(99 %)
6 diff
(99.1 %id)
DA799199 brain TBC1D14.b 1797 to 2337 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
CN358110 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 1808 to 2473 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
DA790375 brain TBC1D14.b 1819 to 2352 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
AW503759 lymph TBC1D14.b 1822 to 2208 1 to 387       387/387
(100 %)
5 diff
(98.8 %id)
TI_154159736   TBC1D14.b 1828 to 2313 84 to 569       486/487
(99 %)
4 diff
(99.2 %id)
DA994466 synovial membrane tissue from rheumatioidarthritis TBC1D14.b 1835 to 2382 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB033921 testis TBC1D14.b 1842 to 2415 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
AI745593 Prostate TBC1D14.b 1845 to 2499 653 to 1       653/653
(100 %)
11 diff
(98.4 %id)
DA781345 brain TBC1D14.b 1863 to 2433 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA405131 thalamus TBC1D14.b 1875 to 2419 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA777070 brain TBC1D14.b 1878 to 2446 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DB155978 thymus TBC1D14.b 1928 to 2524 9 to 605   capped   597/604
(98 %)
0 diff
(100 %id)
DA505966 brain TBC1D14.b 1931 to 2487 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA502118 brain TBC1D14.b 1932 to 2499 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BU430507 lymph TBC1D14.b 1935 to 2342 8 to 416       409/416
(98 %)
11 diff
(97.4 %id)
TI_154151926   TBC1D14.b 1935 to 2609 80 to 757       678/681
(99 %)
57 diff
(91.7 %id)
DA026129   TBC1D14.b 1937 to 2501 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA751790   TBC1D14.b 1941 to 2508 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA991636 synovial membrane tissue from rheumatioidarthritis TBC1D14.b 1941 to 2485 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA736812   TBC1D14.b 1958 to 2796 2 to 841   capped   840/840
(100 %)
3 diff
(99.7 %id)
BQ216261 embryonal carcinoma, cell line, testis TBC1D14.b 1970 to 2793 1 to 829       829/831
(99 %)
7 diff
(99.2 %id)
DB100223 testis TBC1D14.b 1973 to 2552 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA778308 brain TBC1D14.b 1979 to 2529 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CA449659 Chondrosarcoma, Left Pelvis TBC1D14.b 1984 to 2687 722 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 704/704
(100 %)
1 diff
(99.9 %id)
DA765467 tongue TBC1D14.b 1987 to 2578 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DB165717 thymus TBC1D14.b 1993 to 2563 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AA213527 germinal center B cell TBC1D14.b 2000 to 2342 1 to 348       348/348
(100 %)
4 diff
(98.9 %id)
BG258607 embryonal carcinoma, cell line, testis TBC1D14.b 2012 to 2767 1 to 744       744/945
(78 %)
25 diff
(97.4 %id)
CN358114 embryonic stem cells, DMSO-treated H9 cellline TBC1D14.b 2026 to 2541 1 to 516       516/516
(100 %)
0 diff
(100 %id)
DA529950 brain TBC1D14.b 2028 to 2639 2 to 613   capped   612/612
(100 %)
0 diff
(100 %id)
DA171230 amygdala TBC1D14.b 2029 to 2570 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA448138 tongue, tumor tissue TBC1D14.b 2043 to 2583 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA152822 amygdala TBC1D14.b 2051 to 2624 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB138507 thymus TBC1D14.b 2058 to 2581 2 to 525   capped   524/524
(100 %)
2 diff
(99.7 %id)
AI857996 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) TBC1D14.b 2066 to 2686 621 to 1       621/621
(100 %)
6 diff
(99.1 %id)
BU154514 leiomyosarcoma, uterus TBC1D14.b 2117 to 2968 1 to 861       861/903
(95 %)
11 diff
(98.8 %id)
CN358115 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TBC1D14.b 2118 to 2579 1 to 462       462/462
(100 %)
3 diff
(99.4 %id)
BG391590 embryonal carcinoma, cell line, testis TBC1D14.b 2120 to 2762 1 to 642       642/642
(100 %)
4 diff
(99.4 %id)
DA496914 brain TBC1D14.b 2126 to 2689 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BM480322 duodenal adenocarcinoma, cell line, small intestine TBC1D14.b 2162 to 3181 1 to 1013       1013/1034
(97 %)
35 diff
(96.7 %id)
BE838166 prostate_normal TBC1D14.b 2253 to 2628 1 to 374       374/374
(100 %)
12 diff
(96.8 %id)
CN358113 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 2253 to 2971 1 to 720       720/720
(100 %)
1 diff
(99.9 %id)
BE700996 nervous_normal TBC1D14.b 2255 to 2662 7 to 416       410/418
(98 %)
16 diff
(96.2 %id)
DB016944 esophageal, tumor tissue TBC1D14.b 2258 to 2827 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BE771914 prostate_tumor TBC1D14.b 2265 to 2560 295 to 2       294/295
(99 %)
0 diff
(100 %id)
BE830809 marrow TBC1D14.b 2266 to 2670 1 to 405       405/405
(100 %)
4 diff
(99.1 %id)
BE771887 prostate_tumor TBC1D14.b 2292 to 2606 11 to 325       315/325
(96 %)
8 diff
(97.6 %id)
BE838181 prostate_normal TBC1D14.b 2294 to 2600 12 to 319       308/319
(96 %)
6 diff
(98.2 %id)
CN358112 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TBC1D14.b 2297 to 2809 1 to 513       513/513
(100 %)
0 diff
(100 %id)
AA743446 germinal center B cell TBC1D14.b 2307 to 2622 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
TI_153957889   TBC1D14.b 2308 to 2826 75 to 592       518/1424
(36 %)
21 diff
(98.6 %id)
CN358119 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 2315 to 2957 1 to 643       643/643
(100 %)
0 diff
(100 %id)
DA498740 brain TBC1D14.b 2318 to 2873 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AA766172 germinal center B cell TBC1D14.b 2319 to 2616 298 to 1       298/298
(100 %)
0 diff
(100 %id)
CB266638 adipose TBC1D14.b 2338 to 2870 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BU186550 large cell carcinoma, lung TBC1D14.b 2447 to 3285 1 to 845       845/904
(93 %)
23 diff
(97.5 %id)
CN358122 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TBC1D14.b 2455 to 2806 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
DA502858 brain TBC1D14.b 2473 to 3024 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA771882 brain TBC1D14.b 2473 to 3051 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA736462   TBC1D14.b 2481 to 3231 2 to 750   capped   749/753
(99 %)
3 diff
(99.7 %id)
DA509389 brain TBC1D14.b 2495 to 3050 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
CN358121 embryonic stem cells, DMSO-treated H9 cellline TBC1D14.b 2516 to 3252 1 to 737       737/737
(100 %)
3 diff
(99.6 %id)
DA840813 placenta TBC1D14.b 2516 to 3065 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA529745 brain TBC1D14.b 2521 to 3132 2 to 613   capped   612/612
(100 %)
1 diff
(99.9 %id)
AA214543 germinal center B cell TBC1D14.b 2535 to 2688 154 to 1       154/158
(97 %)
0 diff
(100 %id)
DA768568 brain TBC1D14.b 2537 to 3025 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
BF310721 brain, neuroblastoma TBC1D14.b 2540 to 3234 1 to 694       694/959
(72 %)
42 diff
(95.7 %id)
FN074143 breast carcinoma TBC1D14.b 2549 to 2605 1 to 57       57/57
(100 %)
3 diff
(94.8 %id)
BE838167 prostate_normal TBC1D14.b 2551 to 2724 10 to 183       174/183
(95 %)
6 diff
(96.8 %id)
BM045773 carcinoma, cell line, Prostate TBC1D14.b 2552 to 3137 1 to 588       588/589
(99 %)
7 diff
(98.9 %id)
DA688857   TBC1D14.b 2646 to 3217 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BE260124 brain, neuroblastoma TBC1D14.b 2681 to 3277 1 to 598       598/600
(99 %)
12 diff
(98.0 %id)
AA334162   TBC1D14.b 2696 to 3020 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
DA308249 hippocampus TBC1D14.b 2718 to 3308 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
DA032051   TBC1D14.b 2734 to 3294 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
R47421   TBC1D14.b 2735 to 2982 1 to 248       248/250
(99 %)
2 diff
(99.2 %id)
DA827899 placenta TBC1D14.b 2739 to 3388 2 to 652   capped   651/657
(99 %)
3 diff
(99.6 %id)
AA354950   TBC1D14.b 2744 to 3116 1 to 382       382/382
(100 %)
11 diff
(97.2 %id)
DA161730 amygdala TBC1D14.b 2750 to 3321 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA499180 brain TBC1D14.b 2770 to 3337 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA511615 brain TBC1D14.b 2770 to 3342 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA380944 thalamus TBC1D14.b 2777 to 3323 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
DA735604   TBC1D14.b 2780 to 3529 2 to 751   capped   750/752
(99 %)
5 diff
(99.4 %id)
DA510672 brain TBC1D14.b 2781 to 3349 2 to 570   capped   569/570
(99 %)
1 diff
(99.9 %id)
CN358111 embryonic stem cells, DMSO-treated H9 cellline TBC1D14.b 2782 to 3453 1 to 672       672/672
(100 %)
4 diff
(99.5 %id)
DA341166 substantia nigra TBC1D14.b 2790 to 3337 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BG392410 embryonal carcinoma, cell line, testis TBC1D14.b 2791 to 3636 1 to 840       840/952
(88 %)
26 diff
(97.3 %id)
DA826422 pericardium TBC1D14.b 2797 to 3347 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BG258910 embryonal carcinoma, cell line, testis TBC1D14.b 2809 to 3482 1 to 667       667/947
(70 %)
11 diff
(98.9 %id)
DA795835 brain TBC1D14.b 2816 to 3354 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BF304196 muscle, rhabdomyosarcoma TBC1D14.b 2837 to 3629 1 to 799       799/800
(99 %)
35 diff
(95.7 %id)
BF791541 adrenal cortex carcinoma, cell line, adrenal gland TBC1D14.b 2859 to 3470 1 to 625       625/837
(74 %)
29 diff
(96.6 %id)
BY798342 eye TBC1D14.b 2875 to 3398 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BG256884 embryonal carcinoma, cell line, testis TBC1D14.b 2881 to 3048 1 to 168       168/168
(100 %)
0 diff
(100 %id)
BM706195 eye, lens TBC1D14.b 2892 to 3256 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
BE885674 leiomyosarcoma, uterus TBC1D14.b 2902 to 3563 1 to 652       652/934
(69 %)
21 diff
(97.8 %id)
DA829841 placenta TBC1D14.b 2909 to 3664 2 to 763   capped   762/773
(98 %)
15 diff
(98.1 %id)
DA520202 brain TBC1D14.b 2917 to 3461 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA682468 ovary TBC1D14.b 2935 to 3494 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
DA022306   TBC1D14.b 2942 to 3503 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BG422087 Kidney, renal cell adenocarcinoma TBC1D14.b 2946 to 3569 10 to 632       623/632
(98 %)
6 diff
(99.1 %id)
CU444488 epidermis TBC1D14.b 3016 to 3452 11 to 447       437/455
(96 %)
7 diff
(98.5 %id)
CF551951 Pooled muscle (cardiac and skeletal) TBC1D14.b 3077 to 3868 33 to 832       800/897
(89 %)
33 diff
(96.4 %id)
BG674493 skin TBC1D14.b 3130 to 3800 1 to 678       678/898
(75 %)
22 diff
(97.6 %id)
CN358120 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 3150 to 3401 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
AA045321 uterus TBC1D14.b 3151 to 3546 401 to 1       401/401
(100 %)
8 diff
(98.1 %id)
CD251813 testis TBC1D14.b 3153 to 3975 1 to 825       825/825
(100 %)
6 diff
(99.3 %id)
BF974050 leiomyosarcoma cell line, uterus TBC1D14.b 3164 to 3921 1 to 750       750/752
(99 %)
17 diff
(97.8 %id)
AA309590   TBC1D14.b 3165 to 3627 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
BF972522 leiomyosarcoma cell line, uterus TBC1D14.b 3168 to 3898 9 to 753       745/1011
(73 %)
35 diff
(96.6 %id)
DA276640 corpus callosum TBC1D14.b 3220 to 3792 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CA392978 eye, RPE/choroid TBC1D14.b 3325 to 3930 1 to 607       607/607
(100 %)
4 diff
(99.4 %id)
CD172469 White Matter TBC1D14.b 3326 to 4143 1 to 822       822/855
(96 %)
4 diff
(99.6 %id)
BF820305 kidney_tumor TBC1D14.b 3332 to 3806 1 to 478       478/478
(100 %)
20 diff
(95.9 %id)
BI859657 breast, mammary adenocarcinoma, cell line TBC1D14.b 3341 to 4134 1 to 796       796/799
(99 %)
6 diff
(99.3 %id)
TI_57188991   TBC1D14.b 3341 to 4134 55 to 850       796/799
(99 %)
6 diff
(99.3 %id)
BF820292 kidney_tumor TBC1D14.b 3342 to 3800 13 to 472       460/472
(97 %)
6 diff
(98.8 %id)
R28203 placenta TBC1D14.b 3356 to 3663 1 to 315       315/333
(94 %)
8 diff
(97.6 %id)
Z43360 brain, total brain TBC1D14.b 3376 to 3615 1 to 240       240/240
(100 %)
0 diff
(100 %id)
AW295138   TBC1D14.b 3378 to 3802 434 to 10       425/439
(96 %)
0 diff
(100 %id)
BE898708 adenocarcinoma cell line, ovary TBC1D14.b 3382 to 4166 1 to 766       766/854
(89 %)
19 diff
(97.8 %id)
DA176156 amygdala TBC1D14.b 3385 to 3948 2 to 565   capped   564/566
(99 %)
1 diff
(99.9 %id)
Z78361 brain TBC1D14.b 3390 to 3795 1 to 407       407/411
(99 %)
25 diff
(94.0 %id)
T27001   TBC1D14.b 3401 to 3781 1 to 379       379/379
(100 %)
7 diff
(98.2 %id)
Z45494 brain, total brain TBC1D14.b 3408 to 3723 1 to 316       316/316
(100 %)
0 diff
(100 %id)
H05373 whole brain TBC1D14.b 3409 to 3778 1 to 373       373/491
(75 %)
8 diff
(98.4 %id)
H86329 eye, retina TBC1D14.b 3432 to 3854 1 to 433       433/433
(100 %)
19 diff
(95.7 %id)
AA058989 eye, retina TBC1D14.b 3433 to 3611 1 to 179     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 179/181
(98 %)
1 diff
(99.5 %id)
CF121126 CNCAP(3)T-225 cell line, Prostate TBC1D14.b 3441 to 4107 1 to 667       667/667
(100 %)
10 diff
(98.6 %id)
CF121154 CNCAP(3)T-225 cell line, Prostate TBC1D14.b 3441 to 4106 1 to 665       665/665
(100 %)
8 diff
(98.8 %id)
H15064 whole brain TBC1D14.b 3448 to 3914 1 to 470     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 470/550
(85 %)
8 diff
(98.6 %id)
TI_154180117   TBC1D14.b 3448 to 4278 76 to 906       831/831
(100 %)
12 diff
(98.6 %id)
TI_154180156   TBC1D14.b 3448 to 4295 76 to 922       847/852
(99 %)
13 diff
(98.5 %id)
AA486318   TBC1D14.b 3450 to 3891 1 to 439   fully sequenced,   439/439
(100 %)
3 diff
(99.4 %id)
D56273   TBC1D14.b 3456 to 3810 1 to 352       352/352
(100 %)
3 diff
(99.2 %id)
DA076644 cerebellum TBC1D14.b 3467 to 4051 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
CD703663 normal nasopharynx TBC1D14.b 3481 to 4002 26 to 545       520/545
(95 %)
6 diff
(98.9 %id)
BG910987 anaplastic oligodendroglioma with 1p/19qloss, brain TBC1D14.b 3493 to 4268 1 to 786       786/928
(84 %)
30 diff
(96.8 %id)
R14815 whole brain TBC1D14.b 3511 to 3956 1 to 454     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 454/454
(100 %)
25 diff
(94.5 %id)
CA390329 eye, RPE/choroid TBC1D14.b 3518 to 4085 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BG177102 lymph, lymphoma, cell line TBC1D14.b 3525 to 4261 1 to 723       723/967
(74 %)
21 diff
(97.9 %id)
N92062 liver and spleen TBC1D14.b 3526 to 3958 1 to 434       434/434
(100 %)
4 diff
(99.1 %id)
AA135600.
matches multiple genes
uterus TBC1D14.b 3528 to 4155 1 to 622     also hits gene JARID2 622/627
(99 %)
29 diff
(95.4 %id)
AA115282 uterus TBC1D14.b 3529 to 4078 1 to 548       548/549
(99 %)
7 diff
(98.8 %id)
R24567 whole brain TBC1D14.b 3530 to 3919 1 to 398     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 398/401
(99 %)
17 diff
(95.8 %id)
Z42594 brain, total brain TBC1D14.b 3543 to 3840 1 to 297       297/297
(100 %)
3 diff
(99.0 %id)
H06692 whole brain TBC1D14.b 3544 to 4029 1 to 500       500/513
(97 %)
34 diff
(93.4 %id)
H19010 whole brain TBC1D14.b 3544 to 4007 1 to 470     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 470/473
(99 %)
18 diff
(96.2 %id)
BQ720363 sympathetic trunk TBC1D14.b 3547 to 4345 1 to 803       803/915
(87 %)
21 diff
(97.8 %id)
F11186 brain, total brain TBC1D14.b 3551 to 3896 1 to 346       346/346
(100 %)
1 diff
(99.8 %id)
R35155 whole brain TBC1D14.b 3552 to 3914 1 to 372       372/376
(98 %)
17 diff
(95.5 %id)
BE905950 epithelioid carcinoma, Pancreas TBC1D14.b 3566 to 4226 1 to 659       659/659
(100 %)
3 diff
(99.6 %id)
H08014 whole brain TBC1D14.b 3570 to 4048 1 to 486     Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 486/486
(100 %)
19 diff
(96.1 %id)
BU601985 mixed (pool of 40 RNAs) TBC1D14.b 3584 to 4395 1 to 814       814/814
(100 %)
19 diff
(97.7 %id)
BF574487 muscle (skeletal) TBC1D14.b 3587 to 4244 1 to 656       656/704
(93 %)
20 diff
(97.2 %id)
Z42850 brain, total brain TBC1D14.b 3590 to 3929 1 to 340       340/340
(100 %)
6 diff
(98.3 %id)
BF924522 nervous_tumor TBC1D14.b 3621 to 3936 3 to 319       317/319
(99 %)
6 diff
(98.2 %id)
BF924674 nervous_tumor TBC1D14.b 3621 to 4012 3 to 396       394/396
(99 %)
5 diff
(98.8 %id)
BI048527 testis_normal TBC1D14.b 3630 to 3891 46 to 298       253/298
(84 %)
6 diff
(98.0 %id)
BG253298 adenocarcinoma, cell line, Liver TBC1D14.b 3643 to 4420 1 to 758       758/932
(81 %)
35 diff
(96.3 %id)
CN358118 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 3670 to 4276 19 to 625       607/625
(97 %)
6 diff
(99.1 %id)
BU071962 Pancreas, Purified pancreatic islet TBC1D14.b 3672 to 4224 4 to 556       553/556
(99 %)
12 diff
(97.9 %id)
BE892130 melanotic melanoma, skin TBC1D14.b 3691 to 4277 1 to 591       591/844
(70 %)
20 diff
(97.7 %id)
AA342628 Spleen TBC1D14.b 3703 to 3924 221 to 1       221/221
(100 %)
4 diff
(98.2 %id)
F08378 brain, total brain TBC1D14.b 3703 to 3894 1 to 191       191/191
(100 %)
2 diff
(99.0 %id)
H14744 whole brain TBC1D14.b 3704 to 4134 1 to 441       441/475
(92 %)
32 diff
(93.3 %id)
AA486216   TBC1D14.b 3704 to 3861 156 to 1   fully sequenced,   156/156
(100 %)
2 diff
(98.8 %id)
H54356 liver and spleen TBC1D14.b 3764 to 4216 13 to 477       465/479
(97 %)
26 diff
(94.6 %id)
AW149456 brain, medulloblastoma TBC1D14.b 3778 to 4320 543 to 1       543/543
(100 %)
4 diff
(99.3 %id)
AA291762 ovarian tumor, ovary TBC1D14.b 3780 to 4188 16 to 424       409/424
(96 %)
10 diff
(97.7 %id)
BG912640 anaplastic oligodendroglioma with 1p/19qloss, brain TBC1D14.b 3806 to 4397 28 to 619   available from MGC,   592/619
(95 %)
9 diff
(98.6 %id)
BQ937820 leiomyosarcoma, uterus TBC1D14.b 3806 to 4687 1 to 894       894/917
(97 %)
23 diff
(97.5 %id)
Z42064 brain, total brain TBC1D14.b 3809 to 3999 1 to 191       191/191
(100 %)
2 diff
(99.0 %id)
R27093 placenta TBC1D14.b 3809 to 4146 1 to 346       346/363
(95 %)
26 diff
(92.9 %id)
BC024966 Brain, anaplastic oligodendroglioma with1p/19q loss TBC1D14.b 3813 to 5083 1 to 1271   available from MGC, AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 1271/1271
(100 %)
1 diff
(100.0 %id)
AW951962   TBC1D14.b 3859 to 4215 8 to 364       357/365
(97 %)
1 diff
(99.8 %id)
AA316474 colon TBC1D14.b 3861 to 4206 10 to 355       346/355
(97 %)
6 diff
(98.4 %id)
CR979276 T-Lymphocytes TBC1D14.b 3862 to 4430 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BY997050   TBC1D14.b 3864 to 4520 10 to 666       657/666
(98 %)
6 diff
(99.1 %id)
D81559 brain TBC1D14.b 3884 to 4263 1 to 380       380/380
(100 %)
0 diff
(100 %id)
BP431990   TBC1D14.b 3971 to 4212 7 to 248       242/248
(97 %)
6 diff
(97.6 %id)
AL541075 placenta TBC1D14.b 3994 to 4950 1 to 952       952/1060
(89 %)
14 diff
(98.7 %id)
BX117710 liver and spleen TBC1D14.b 3999 to 4675 1 to 677       677/677
(100 %)
1 diff
(99.9 %id)
N72449 liver and spleen TBC1D14.b 4022 to 4267 1 to 245       245/245
(100 %)
14 diff
(94.3 %id)
N98443 liver and spleen TBC1D14.b 4025 to 4479 1 to 449   fully sequenced,   449/449
(100 %)
10 diff
(97.8 %id)
H59564 liver and spleen TBC1D14.b 4061 to 4454 1 to 399       399/427
(93 %)
17 diff
(96.1 %id)
BI860317 breast, mammary adenocarcinoma, cell line TBC1D14.b 4063 to 4800 1 to 741       741/741
(100 %)
5 diff
(99.4 %id)
BM801130 embryonal carcinoma, cell line, testis TBC1D14.b 4063 to 4879 1 to 823       823/945
(87 %)
43 diff
(95.5 %id)
TI_57190071   TBC1D14.b 4063 to 4800 61 to 801       741/741
(100 %)
5 diff
(99.4 %id)
R94795 liver and spleen TBC1D14.b 4083 to 4422 1 to 342       342/344
(99 %)
13 diff
(96.3 %id)
H84049 melanocyte TBC1D14.b 4084 to 4454 1 to 374       374/418
(89 %)
16 diff
(96.2 %id)
BQ669371 epidermoid carcinoma, cell line, salivary gland TBC1D14.b 4097 to 4902 1 to 807       807/945
(85 %)
12 diff
(98.8 %id)
CK024100 brain/CNS, Human Brain - Frontal Cortex TBC1D14.b 4103 to 4777 1 to 667       667/697
(95 %)
15 diff
(97.9 %id)
CN358108 embryonic stem cells, cell lines H1, H7, andH9 TBC1D14.b 4115 to 4817 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
AV691422 hepatocellular carcinoma TBC1D14.b 4142 to 4704 1 to 563       563/593
(94 %)
26 diff
(95.7 %id)
AV692519 hepatocellular carcinoma TBC1D14.b 4142 to 4739 1 to 592       592/592
(100 %)
29 diff
(95.2 %id)
AA425718 ovarian tumor, ovary TBC1D14.b 4154 to 4636 1 to 482       482/482
(100 %)
7 diff
(98.6 %id)
R94384 liver and spleen TBC1D14.b 4172 to 4591 1 to 430       430/475
(90 %)
20 diff
(95.8 %id)
N63916 liver and spleen TBC1D14.b 4463 to 5083 621 to 1   fully sequenced,   621/621
(100 %)
2 diff
(99.7 %id)
N53446 liver and spleen TBC1D14.b 4489 to 5084 604 to 2   tiling clone,   603/604
(99 %)
0 diff
(100 %id)
BU075963 Pancreas, Purified pancreatic islet TBC1D14.b 4528 to 5073 546 to 1       546/546
(100 %)
0 diff
(100 %id)
DB368943   TBC1D14.b 4530 to 5083 562 to 1       562/566
(99 %)
15 diff
(97.4 %id)
DB367907   TBC1D14.b 4540 to 5083 541 to 1       541/543
(99 %)
6 diff
(98.9 %id)
DB368299   TBC1D14.b 4570 to 5081 514 to 1       514/514
(100 %)
16 diff
(96.9 %id)
DB374780 placenta TBC1D14.b 4572 to 5083 513 to 1       513/558
(91 %)
24 diff
(95.7 %id)
DB372258 placenta TBC1D14.b 4576 to 5082 505 to 1       505/515
(98 %)
11 diff
(97.9 %id)
DB369378   TBC1D14.b 4590 to 5083 494 to 1       494/497
(99 %)
5 diff
(99.0 %id)
H15065 whole brain TBC1D14.b 4596 to 5083 514 to 16   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 499/499
(100 %)
14 diff
(97.2 %id)
R26864 placenta TBC1D14.b 4607 to 5083 482 to 1       482/489
(98 %)
19 diff
(96.2 %id)
H16393 whole brain TBC1D14.b 4644 to 5084 451 to 3       449/451
(99 %)
0 diff
(100 %id)
AA115260 uterus TBC1D14.b 4644 to 5083 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
AA426545 ovarian tumor, ovary TBC1D14.b 4656 to 5083 428 to 1       428/428
(100 %)
0 diff
(100 %id)
H54277 liver and spleen TBC1D14.b 4697 to 5084 398 to 2       397/398
(99 %)
0 diff
(100 %id)
H84050 melanocyte TBC1D14.b 4697 to 5076 392 to 1       392/393
(99 %)
14 diff
(96.5 %id)
R94714 liver and spleen TBC1D14.b 4706 to 5053 361 to 1       361/367
(98 %)
21 diff
(94.3 %id)
H07918 whole brain TBC1D14.b 4713 to 5082 387 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 376/384
(97 %)
14 diff
(96.4 %id)
R27956 placenta TBC1D14.b 4739 to 5081 349 to 1       349/550
(63 %)
8 diff
(98.6 %id)
Z38773 brain, total brain TBC1D14.b 4761 to 5083 323 to 1       323/323
(100 %)
0 diff
(100 %id)
H19306 whole brain TBC1D14.b 4768 to 5083 328 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 317/320
(99 %)
3 diff
(99.1 %id)
N68849 liver and spleen TBC1D14.b 4771 to 5083 315 to 1       363/405
(89 %)
15 diff
(96.3 %id)
R44372 whole brain TBC1D14.b 4782 to 5082 318 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 307/310
(99 %)
13 diff
(95.9 %id)
F08853 brain, total brain TBC1D14.b 4786 to 5083 298 to 1       298/298
(100 %)
0 diff
(100 %id)
F04359 brain, total brain TBC1D14.b 4798 to 5083 286 to 1       286/286
(100 %)
0 diff
(100 %id)
R40121 whole brain TBC1D14.b 4805 to 5083 300 to 11   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 290/294
(98 %)
12 diff
(96.0 %id)
F02319 brain, total brain TBC1D14.b 4813 to 5083 271 to 1       271/271
(100 %)
0 diff
(100 %id)
F01594 brain, total brain TBC1D14.b 4820 to 5083 264 to 1       264/264
(100 %)
0 diff
(100 %id)
F04602 brain, total brain TBC1D14.b 4820 to 5083 264 to 1       264/264
(100 %)
0 diff
(100 %id)
T27000   TBC1D14.b 4911 to 5083 173 to 1       173/180
(96 %)
1 diff
(99.5 %id)
AA059019 eye, retina TBC1D14.b 4960 to 5083 145 to 22   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 124/124
(100 %)
0 diff
(100 %id)
BQ230652 epithelioid carcinoma, Pancreas TBC1D14.c 1 to 832 1 to 835   tiling clone,   835/862
(96 %)
8 diff
(99.1 %id)
NM_001113363.1   TBC1D14.c 1 to 4153 1 to 4153 exact RefSeq,   4153/4153
(100 %)
0 diff
(100 %id)
BX460475 brain, fetal brain TBC1D14.c 51 to 983 1 to 933   tiling clone,   933/933
(100 %)
0 diff
(100 %id)
DC335309 hippocampus TBC1D14.c 82 to 685 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
DC415638 trachea TBC1D14.c 84 to 630 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC423159 uterus TBC1D14.c 84 to 626 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DC321378 brain TBC1D14.c 110 to 584 1 to 475       475/475
(100 %)
0 diff
(100 %id)
CD652454 Embryonic Stem cells TBC1D14.c 124 to 934 12 to 818       807/848
(95 %)
22 diff
(97.5 %id)
DC334039 hippocampus TBC1D14.c 131 to 657 1 to 527       527/527
(100 %)
0 diff
(100 %id)
DC334043 hippocampus TBC1D14.c 131 to 671 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC334245 hippocampus TBC1D14.c 137 to 687 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BG914339 anaplastic oligodendroglioma with 1p/19qloss, brain TBC1D14.c 138 to 677 37 to 590       554/991
(55 %)
21 diff
(97.9 %id)
DC372797   TBC1D14.c 146 to 686 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC400912 testis TBC1D14.c 146 to 702 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM462855 melanotic melanoma, skin TBC1D14.c 149 to 995 1 to 852   tiling clone,   852/1003
(84 %)
12 diff
(98.9 %id)
DC377551 brain TBC1D14.d 1 to 555 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC399948 testis TBC1D14.d 1 to 532 1 to 533   tiling clone,   533/552
(96 %)
4 diff
(99.3 %id)
AK295068 brain TBC1D14.d 358 to 1826 1 to 1469   tiling clone,   1469/1469
(100 %)
2 diff
(99.9 %id)
DC324252 brain TBC1D14.d 358 to 959 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
CK000772 mixed TBC1D14.e 1 to 789 1 to 789   tiling clone,   789/791
(99 %)
8 diff
(99.0 %id)
BE835617 prostate_normal TBC1D14.e 725 to 977 1 to 253   tiling clone,   253/260
(97 %)
6 diff
(97.7 %id)
DB241199 trachea TBC1D14.f 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
DA500549 brain TBC1D14.f 429 to 977 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA788643 brain TBC1D14.f 487 to 1068 2 to 583   tiling clone, capped   582/582
(100 %)
1 diff
(99.9 %id)
DA239448 brain TBC1D14.g 1 to 595 2 to 599   tiling clone, capped   598/598
(100 %)
2 diff
(99.7 %id)
EL594500 epidermis, skin TBC1D14.g 283 to 903 25 to 646   tiling clone,   622/668
(93 %)
12 diff
(98.3 %id)
BF333558 colon_normal TBC1D14.g 538 to 905 1 to 365   tiling clone,   365/377
(96 %)
15 diff
(96.1 %id)
BI023601 marrow TBC1D14.g 568 to 836 273 to 9       265/281
(94 %)
0 diff
(100 %id)
BI023268 marrow TBC1D14.g 672 to 826 9 to 162   tiling clone,   154/162
(95 %)
6 diff
(96.3 %id)
AK056962 skeletal muscle TBC1D14.h 1 to 1780 2 to 1781   tiling clone, available from FLJ,   1781/1781
(100 %)
1 diff
(100.0 %id)
DA893229 skeletal muscle TBC1D14.h 1 to 521 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
DB330883 skeletal muscle TBC1D14.h 1234 to 1780 548 to 1       548/548
(100 %)
1 diff
(99.9 %id)
DN991647 brain, whole brain TBC1D14.i-u 1 to 595 7 to 600   tiling clone,   594/600
(99 %)
2 diff
(99.7 %id)
AK091893 Kidney TBC1D14.i-u 303 to 2441 1 to 2139 T2A G125R tiling clone, available from FLJ,   2139/2139
(100 %)
17 diff
(99.3 %id)
AX747238   TBC1D14.i-u 303 to 2441 1 to 2139 T2A G125R     2139/2139
(100 %)
17 diff
(99.3 %id)
DA627718 Kidney TBC1D14.i-u 304 to 835 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA636272 Kidney TBC1D14.i-u 641 to 1217 2 to 579   tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
DB320707 Kidney TBC1D14.i-u 1915 to 2441 527 to 1       527/527
(100 %)
13 diff
(97.6 %id)
DA413344 thalamus TBC1D14.j-u 1 to 550 2 to 551   tiling clone, capped   550/550
(100 %)
4 diff
(99.3 %id)
BX479300   TBC1D14.j-u 345 to 668 1 to 324   tiling clone,   324/325
(99 %)
2 diff
(99.4 %id)
DA101393 cerebellum TBC1D14.j-u 419 to 975 2 to 558 Y33* capped   557/557
(100 %)
9 diff
(98.4 %id)
DB157231 thymus TBC1D14.j-u 447 to 1027 2 to 583 R27X G28W G29W T30H P31T ... tiling clone, capped   582/582
(100 %)
4 diff
(99.4 %id)
CR990614 T-Lymphocytes TBC1D14.j-u 886 to 1761 1 to 875   tiling clone,   875/875
(100 %)
3 diff
(99.7 %id)
DB163044 thymus TBC1D14.j-u 982 to 1569 2 to 589   tiling clone, capped   588/588
(100 %)
2 diff
(99.7 %id)
BX642105   TBC1D14.j-u 1068 to 1469 9 to 410       402/410
(98 %)
6 diff
(98.6 %id)
AL118870 amygdala TBC1D14.j-u 1225 to 1707 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
BX642106   TBC1D14.j-u 3374 to 4011 638 to 1   tiling clone,   638/638
(100 %)
1 diff
(99.9 %id)
DB299149 cerebellum TBC1D14.j-u 3495 to 4024 530 to 1   tiling clone,   530/530
(100 %)
1 diff
(99.9 %id)
DB071650 testis TBC1D14.k 1 to 540 2 to 542 R24X T25D L26P L27P L28P ... tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
CB053685 leiomyosarcoma, soft tissue TBC1D14.l 1 to 424 10 to 433 V26D tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 424/433
(97 %)
7 diff
(98.4 %id)
TI_151750724   TBC1D14.l 14 to 1003 1099 to 127   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 973/1100
(88 %)
107 diff
(90.3 %id)
CF618890 Pooled Chondrosarcoma Tumor cells TBC1D14.l 86 to 870 9 to 818       810/924
(87 %)
36 diff
(96.2 %id)
CF618889 Pooled Chondrosarcoma Tumor cells TBC1D14.l 86 to 796 9 to 730       722/909
(79 %)
26 diff
(97.2 %id)
BF670039 brain, primitive neuroectoderm TBC1D14.l 87 to 871 1 to 785       785/825
(95 %)
45 diff
(94.6 %id)
BG535795 lung TBC1D14.l 94 to 795 1 to 704       704/774
(90 %)
32 diff
(95.9 %id)
BI519828 leukocyte TBC1D14.l 146 to 947 826 to 2       825/1055
(78 %)
0 diff
(100 %id)
TI_44460294   TBC1D14.l 146 to 947 826 to 2       825/1055
(78 %)
0 diff
(100 %id)
AV750931 Pituitary TBC1D14.l 154 to 515 1 to 357       357/365
(97 %)
4 diff
(99.0 %id)
AV747771 Pituitary TBC1D14.l 155 to 685 1 to 523       523/528
(99 %)
15 diff
(97.2 %id)
CD250460 Blood vessels - aorta, basilar and artery TBC1D14.l 156 to 816 1 to 672   tiling clone,   672/775
(86 %)
15 diff
(98.1 %id)
BE906750 epithelioid carcinoma, Pancreas TBC1D14.l 158 to 936 1 to 782       782/867
(90 %)
21 diff
(97.6 %id)
TI_149296988   TBC1D14.l 174 to 1000 892 to 78   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 815/927
(87 %)
16 diff
(98.3 %id)
BM931477 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid TBC1D14.l 175 to 409 1 to 235   fully sequenced, Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 235/235
(100 %)
1 diff
(99.6 %id)
BU607931 Human Lung Epithelial cells, lung TBC1D14.l 207 to 1000 809 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 791/791
(100 %)
3 diff
(99.7 %id)
BG623689 placenta TBC1D14.l 231 to 994 1 to 763       763/781
(97 %)
13 diff
(98.4 %id)
BG251280 adenocarcinoma, cell line, Liver TBC1D14.l 237 to 999 1 to 759       759/976
(77 %)
33 diff
(96.7 %id)
TI_154040412   TBC1D14.l 243 to 1000 885 to 136       750/1026
(73 %)
0 diff
(100 %id)
N25158 melanocyte TBC1D14.l 269 to 772 1 to 517       517/519
(99 %)
6 diff
(98.9 %id)
BP432348   TBC1D14.l 274 to 673 1 to 400       400/400
(100 %)
2 diff
(99.5 %id)
H63158 liver and spleen TBC1D14.l 278 to 677 1 to 410   fully sequenced,   410/410
(100 %)
12 diff
(97.1 %id)
TI_154101186   TBC1D14.l 278 to 1000 799 to 77   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 723/807
(89 %)
6 diff
(99.3 %id)
TI_149303163   TBC1D14.l 294 to 998 783 to 78   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 706/1005
(70 %)
1 diff
(100.0 %id)
AW363695 colon TBC1D14.l 305 to 798 25 to 518       494/520
(95 %)
22 diff
(95.8 %id)
BM981220 lung, Primary Lung Cystic Fibrosis EpithelialCells TBC1D14.l 325 to 998 689 to 16   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 674/674
(100 %)
0 diff
(100 %id)
CN478912 Human Lung Epithelial cells, lung TBC1D14.l 325 to 999 693 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 675/675
(100 %)
1 diff
(99.9 %id)
BQ448680 Knee, Osteoarthritic Cartilage TBC1D14.l 325 to 1000 694 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 676/676
(100 %)
0 diff
(100 %id)
BQ574684 Chondrosarcoma Grade II, Left Pelvis TBC1D14.l 325 to 1000 694 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 676/676
(100 %)
0 diff
(100 %id)
BM982132 lung, Primary Lung Cystic Fibrosis EpithelialCells TBC1D14.l 342 to 1000 677 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 659/659
(100 %)
0 diff
(100 %id)
BQ015528 Chondrosarcoma, Left Pelvis TBC1D14.l 350 to 1000 669 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 651/651
(100 %)
0 diff
(100 %id)
CA418905 Chondrosarcoma Grade II, Left Pelvis TBC1D14.l 350 to 1000 668 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 650/650
(100 %)
1 diff
(99.9 %id)
BI222625 cervical carcinoma cell line, cervix TBC1D14.l 356 to 1002 62 to 710   AAA   649/722
(89 %)
8 diff
(98.9 %id)
TI_151713677   TBC1D14.l 359 to 1000 759 to 118       642/759
(84 %)
0 diff
(100 %id)
N55132 multiple sclerosis lesions TBC1D14.l 368 to 674 1 to 309       309/309
(100 %)
7 diff
(97.8 %id)
BM675605 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid TBC1D14.l 379 to 1000 640 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
CB053684 leiomyosarcoma, soft tissue TBC1D14.l 394 to 1000 630 to 24   fully sequenced, AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 607/607
(100 %)
0 diff
(100 %id)
AA541651 normal prostate, Prostate TBC1D14.l 402 to 999 597 to 1       597/600
(99 %)
7 diff
(98.9 %id)
BQ001226 lung, Metastatic Chondrosarcoma TBC1D14.l 406 to 998 611 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 593/601
(98 %)
0 diff
(100 %id)
H13528 placenta TBC1D14.l 409 to 784 1 to 390       390/460
(84 %)
20 diff
(95.7 %id)
CB043909 colon, juvenile granulosa tumor TBC1D14.l 410 to 1000 611 to 21   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
CA441710 Chondrosarcoma, Left Pubic Bone TBC1D14.l 416 to 1000 603 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
AI858011 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) TBC1D14.l 437 to 1001 567 to 3   tiling clone,   565/567
(99 %)
0 diff
(100 %id)
AA573858 colon, tumor TBC1D14.l 442 to 991 550 to 1       550/550
(100 %)
0 diff
(100 %id)
BF109206 pooled TBC1D14.l 442 to 999 558 to 1       558/558
(100 %)
0 diff
(100 %id)
BF109429 pooled TBC1D14.l 443 to 999 557 to 1       557/557
(100 %)
0 diff
(100 %id)
BG003740 placenta_normal TBC1D14.l 444 to 914 1 to 475       475/475
(100 %)
20 diff
(95.8 %id)
AW150971 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors TBC1D14.l 451 to 1000 551 to 1       551/551
(100 %)
9 diff
(98.4 %id)
BM695044 eye, human retina TBC1D14.l 462 to 816 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BF988473 placenta_normal TBC1D14.l 464 to 590 20 to 147       128/147
(87 %)
6 diff
(96.0 %id)
AA532378 normal prostate, Prostate TBC1D14.l 478 to 999 521 to 1       521/521
(100 %)
7 diff
(98.7 %id)
BF923534 nervous_tumor TBC1D14.l 481 to 990 1 to 510       510/514
(99 %)
19 diff
(96.4 %id)
AW172771 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus TBC1D14.l 483 to 1000 528 to 11   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
AI568454 anaplastic oligodendroglioma, brain TBC1D14.l 491 to 1000 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
BU171790 melanotic melanoma, skin TBC1D14.l 492 to 999 1 to 508       508/537
(94 %)
1 diff
(99.9 %id)
AA857892 colon, colon tumor TBC1D14.l 496 to 1000 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AV726677 hypothalamus TBC1D14.l 499 to 991 48 to 539   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 492/539
(91 %)
6 diff
(98.9 %id)
AI185005 lung TBC1D14.l 504 to 1001 498 to 1       498/498
(100 %)
3 diff
(99.4 %id)
AI740569 pooled TBC1D14.l 504 to 997 494 to 1       494/494
(100 %)
5 diff
(99.0 %id)
BE676307 B-cell, chronic lymphotic leukemia TBC1D14.l 505 to 1001 505 to 9       497/505
(98 %)
0 diff
(100 %id)
BQ023994 placenta TBC1D14.l 523 to 1000 496 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 478/478
(100 %)
0 diff
(100 %id)
AI040894 parathyroid gland, parathyroid tumor TBC1D14.l 524 to 1000 488 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 477/477
(100 %)
0 diff
(100 %id)
AA677515 whole brain TBC1D14.l 529 to 1000 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AA865457 pooled germ cell tumors TBC1D14.l 531 to 998 474 to 7       468/474
(98 %)
0 diff
(100 %id)
CD676115 eye, lens TBC1D14.l 539 to 995 1 to 457       457/457
(100 %)
0 diff
(100 %id)
AA876133 germinal center B cell TBC1D14.l 539 to 1000 481 to 20   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 462/462
(100 %)
0 diff
(100 %id)
AI057543 parathyroid gland, parathyroid tumor TBC1D14.l 540 to 1000 472 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 461/461
(100 %)
0 diff
(100 %id)
AI095739 uterus TBC1D14.l 540 to 1001 463 to 2       462/463
(99 %)
0 diff
(100 %id)
BF940875 brain, oligodendroglioma TBC1D14.l 540 to 1001 465 to 2       464/465
(99 %)
0 diff
(100 %id)
BM992307 Bone, Subchondral Bone TBC1D14.l 543 to 1000 477 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 459/459
(100 %)
1 diff
(99.8 %id)
AW188153 pooled TBC1D14.l 546 to 1001 458 to 3       456/458
(99 %)
0 diff
(100 %id)
AI151432 uterus TBC1D14.l 548 to 1000 464 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
AI970686 normal prostate, Prostate TBC1D14.l 548 to 1001 458 to 5       454/458
(99 %)
0 diff
(100 %id)
AW129493 serous papillary carcinoma, high grade, 2pooled tumors, uterus TBC1D14.l 548 to 1001 461 to 8       454/461
(98 %)
0 diff
(100 %id)
AI271887 Kidney TBC1D14.l 550 to 999 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
H98637 melanocyte TBC1D14.l 551 to 1000 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI093353 uterus TBC1D14.l 551 to 1000 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AW189896 adenocarcinoma, Pancreas TBC1D14.l 552 to 1001 455 to 5       451/455
(99 %)
0 diff
(100 %id)
AI348355 carcinoid, lung TBC1D14.l 555 to 999 452 to 6       447/452
(98 %)
0 diff
(100 %id)
AA708914 uterus TBC1D14.l 556 to 1000 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
AA879134 carcinoid, lung TBC1D14.l 556 to 1001 450 to 5       446/450
(99 %)
0 diff
(100 %id)
AA973591 carcinoid, lung TBC1D14.l 559 to 1001 447 to 5       443/447
(99 %)
0 diff
(100 %id)
AA682557 liver and spleen TBC1D14.l 560 to 995 436 to 1       436/436
(100 %)
2 diff
(99.6 %id)
CA424572 cell lines, Chondrosarcoma TBC1D14.l 563 to 1000 456 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 438/438
(100 %)
0 diff
(100 %id)
AA738302 pooled germ cell tumors TBC1D14.l 564 to 991 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AA918313 pooled TBC1D14.l 564 to 1001 443 to 6       438/443
(98 %)
0 diff
(100 %id)
AI093351 uterus TBC1D14.l 565 to 1001 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI383493 B-cell, chronic lymphotic leukemia TBC1D14.l 568 to 1000 454 to 22   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 433/433
(100 %)
1 diff
(99.8 %id)
AA586346 bulk tumor, colon TBC1D14.l 572 to 1001 431 to 2       430/431
(99 %)
0 diff
(100 %id)
AI016698 Kidney TBC1D14.l 578 to 1000 438 to 16   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
AI139340 uterus TBC1D14.l 578 to 1001 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AW513873 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors TBC1D14.l 578 to 1000 439 to 17   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
AI672698 thymus, pooled TBC1D14.l 585 to 1000 417 to 1       417/419
(99 %)
1 diff
(99.8 %id)
AI299505 carcinoid, lung TBC1D14.l 587 to 999 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AW954153   TBC1D14.l 589 to 1000 1 to 412   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
AI272340 brain, oligodendroglioma TBC1D14.l 589 to 930 343 to 1       343/343
(100 %)
2 diff
(99.5 %id)
T30190 uterus TBC1D14.l 589 to 897 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
BE328772 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney TBC1D14.l 598 to 1001 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA705475 liver and spleen TBC1D14.l 599 to 1000 402 to 1       402/402
(100 %)
0 diff
(100 %id)
W69122 heart TBC1D14.l 600 to 1000 401 to 1       401/403
(99 %)
2 diff
(99.6 %id)
AI025591   TBC1D14.l 600 to 1001 404 to 3       402/404
(99 %)
0 diff
(100 %id)
AI360357 anaplastic oligodendroglioma, brain TBC1D14.l 600 to 1001 403 to 2       402/403
(99 %)
0 diff
(100 %id)
AI537223 poorly differentiated adenocarcinoma withsignet ring cell features, stomach TBC1D14.l 602 to 1001 400 to 2       399/400
(99 %)
0 diff
(100 %id)
BF109809 pooled TBC1D14.l 605 to 999 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AW591435 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors TBC1D14.l 606 to 1001 397 to 2       396/397
(99 %)
0 diff
(100 %id)
T17447   TBC1D14.l 608 to 999 393 to 1       393/393
(100 %)
3 diff
(99.3 %id)
AA291139 germinal center B cell TBC1D14.l 610 to 1000 408 to 18   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
BF445625 brain, glioblastoma (pooled) TBC1D14.l 610 to 1001 393 to 2       392/393
(99 %)
0 diff
(100 %id)
D52505   TBC1D14.l 611 to 981 1 to 371   fully sequenced,   371/371
(100 %)
1 diff
(99.8 %id)
D61231   TBC1D14.l 611 to 935 1 to 326       326/326
(100 %)
4 diff
(98.8 %id)
AA135540 uterus TBC1D14.l 614 to 1000 395 to 1       395/492
(80 %)
8 diff
(98.4 %id)
AA741220 2 pooled tumors (clear cell type), Kidney TBC1D14.l 621 to 1001 385 to 5       381/385
(98 %)
0 diff
(100 %id)
AI927241 poorly differentiated adenocarcinoma withsignet ring cell features, stomach TBC1D14.l 622 to 1000 394 to 16   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
T15919   TBC1D14.l 623 to 1000 382 to 1       382/383
(99 %)
13 diff
(96.7 %id)
AI246009 adenocarcinoma, colon TBC1D14.l 632 to 1000 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AI245518 Kidney TBC1D14.l 634 to 1000 366 to 1       366/375
(97 %)
3 diff
(99.2 %id)
AA974875 2 pooled tumors (clear cell type), Kidney TBC1D14.l 638 to 1001 366 to 3       364/366
(99 %)
0 diff
(100 %id)
BF056126 pooled TBC1D14.l 638 to 1001 364 to 1       364/364
(100 %)
1 diff
(99.8 %id)
BE350497 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney TBC1D14.l 640 to 1001 364 to 3       362/364
(99 %)
0 diff
(100 %id)
H63074 liver and spleen TBC1D14.l 647 to 976 333 to 1   fully sequenced,   333/333
(100 %)
5 diff
(98.5 %id)
AI271787 Kidney TBC1D14.l 647 to 1000 354 to 1       354/354
(100 %)
0 diff
(100 %id)
R43854 whole brain TBC1D14.l 656 to 1000 370 to 11   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 360/364
(98 %)
18 diff
(95.1 %id)
AA721273 germinal center B cell TBC1D14.l 662 to 1000 352 to 14   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
D51046   TBC1D14.l 664 to 1000 335 to 1       335/335
(100 %)
5 diff
(98.6 %id)
AA290769 ovarian tumor, ovary TBC1D14.l 665 to 1000 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
AA548822 normal prostatic epithelial cells, Prostate TBC1D14.l 671 to 969 8 to 306       299/306
(97 %)
6 diff
(98.1 %id)
AA806170 germinal center B cell TBC1D14.l 675 to 1000 338 to 13   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 326/326
(100 %)
0 diff
(100 %id)
AW769993 lymph node, lymphoma, follicular mixed small and largecell TBC1D14.l 678 to 1000 323 to 1       323/323
(100 %)
0 diff
(100 %id)
AA533504 normal prostatic epithelial cells, Prostate TBC1D14.l 681 to 994 1 to 315       315/324
(97 %)
9 diff
(97.3 %id)
BF440005 pooled TBC1D14.l 684 to 1001 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AA724344 parathyroid gland, parathyroid tumor TBC1D14.l 690 to 1005 320 to 5   tiling clone,   316/320
(98 %)
0 diff
(100 %id)
AA917576 Kidney TBC1D14.l 690 to 1000 311 to 1       311/311
(100 %)
0 diff
(100 %id)
EC537598 Prostate TBC1D14.l 691 to 788 7 to 103       97/107
(90 %)
5 diff
(95.4 %id)
AW118549 brain, tumor, 5 pooled (see description) TBC1D14.l 698 to 1000 303 to 1       303/303
(100 %)
0 diff
(100 %id)
AA767619 germinal center B cell TBC1D14.l 701 to 1000 310 to 11   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 300/300
(100 %)
3 diff
(99.0 %id)
F05055 brain, total brain TBC1D14.l 704 to 1000 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AI203502   TBC1D14.l 705 to 1001 316 to 17       300/316
(94 %)
0 diff
(100 %id)
R27965 placenta TBC1D14.l 706 to 998 301 to 1       301/301
(100 %)
12 diff
(96.1 %id)
BU622629 cell lines, Chondrosarcoma TBC1D14.l 713 to 1000 306 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 288/288
(100 %)
0 diff
(100 %id)
H83828 eye, retina TBC1D14.l 714 to 985 272 to 1       272/272
(100 %)
6 diff
(97.8 %id)
AI537924 poorly differentiated adenocarcinoma withsignet ring cell features, stomach TBC1D14.l 718 to 1001 291 to 8       284/291
(97 %)
0 diff
(100 %id)
AA564728 germ cell tumor TBC1D14.l 726 to 1001 277 to 2       276/277
(99 %)
0 diff
(100 %id)
AI204122   TBC1D14.l 727 to 1001 291 to 17       275/291
(94 %)
0 diff
(100 %id)
BU623486 cell lines, Enchondroma TBC1D14.l 728 to 1000 291 to 19   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
AI368540 anaplastic oligodendroglioma, brain TBC1D14.l 730 to 1001 272 to 1       272/272
(100 %)
2 diff
(99.3 %id)
BU963479 mixed (pool of 40 RNAs) TBC1D14.l 740 to 1000 1 to 261   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 261/261
(100 %)
1 diff
(99.7 %id)
AW470568 colon, moderately-differentiated adenocarcinoma TBC1D14.l 745 to 1000 256 to 1       256/256
(100 %)
2 diff
(99.3 %id)
AA917561 Kidney TBC1D14.l 757 to 1000 244 to 1       244/246
(99 %)
6 diff
(97.6 %id)
BQ229230 embryonal carcinoma, cell line, testis TBC1D14.l 757 to 1000 1 to 244   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 244/244
(100 %)
0 diff
(100 %id)
AA740665 Kidney TBC1D14.l 764 to 1001 240 to 3       238/240
(99 %)
0 diff
(100 %id)
AA995419 germ cell tumor TBC1D14.l 768 to 999 232 to 1       232/232
(100 %)
1 diff
(99.6 %id)
AI302335 carcinoid, lung TBC1D14.l 773 to 999 227 to 1       227/228
(99 %)
2 diff
(99.2 %id)
AA705980 parathyroid gland, parathyroid tumor TBC1D14.l 807 to 1000 205 to 12   AAA Possibly primed on the genome, locally A rich (34/34 A in genome downstream of last aligned base) 194/194
(100 %)
4 diff
(98.0 %id)
AI090231 uterus TBC1D14.l 823 to 1000 178 to 1       178/178
(100 %)
0 diff
(100 %id)
AI381196   TBC1D14.l 824 to 1000 177 to 1       177/177
(100 %)
0 diff
(100 %id)
FN149077 breast carcinoma TBC1D14.l 827 to 951 1 to 125       125/127
(98 %)
3 diff
(97.7 %id)
FN128784 breast carcinoma TBC1D14.l 852 to 978 1 to 131       131/131
(100 %)
4 diff
(97.0 %id)
D59997   TBC1D14.l 869 to 998 128 to 1   fully sequenced,   128/128
(100 %)
2 diff
(98.5 %id)
AA948086 pooled TBC1D14.l 878 to 1000 127 to 5       123/127
(96 %)
0 diff
(100 %id)
AA938906 pooled TBC1D14.l 910 to 995 91 to 6       86/91
(94 %)
0 diff
(100 %id)
AA702132 liver and spleen TBC1D14.l 929 to 1000 72 to 1       72/72
(100 %)
0 diff
(100 %id)
DB291608 uterus TBC1D14.m 1 to 590 2 to 591 exact tiling clone, to resequence, capped   590/590
(100 %)
3 diff
(99.5 %id)
DB353067 uterus TBC1D14.m 1255 to 1799 545 to 1   tiling clone, to resequence,   545/545
(100 %)
1 diff
(99.9 %id)
BU929886 placenta TBC1D14.n-u 1 to 781 1 to 801 exact tiling clone,   801/805
(99 %)
24 diff
(97.1 %id)
BI045048 ovary TBC1D14.o-u 1 to 458 1 to 459 K14Q I15L N17H N19T tiling clone,   459/459
(100 %)
21 diff
(95.5 %id)
BI045079 ovary TBC1D14.o-u 1 to 458 1 to 459 K14Q I15L N17H N19T     459/459
(100 %)
21 diff
(95.5 %id)
AF150211 umbilical cord blood TBC1D14.p 1 to 142 6 to 147 exact tiling clone,   147/147
(100 %)
1 diff
(99.4 %id)
BM873691   Gene TBC1D14, variant not shown         This clone was ignored    
CD693331 normal nasopharynx Gene TBC1D14, variant not shown         Suspected internal deletion, this clone was ignored    
N63903 liver and spleen Gene TBC1D14, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
N98274 liver and spleen Gene TBC1D14, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
N95190 lung Gene TBC1D14, variant not shown         Suspected internal deletion, this clone was ignored    
W24591 lung Gene TBC1D14, variant not shown         Suspected internal deletion, this clone was ignored    
AA460612   Gene TBC1D14, variant not shown         Suspected internal deletion, this clone was ignored    
BQ182331 Knee, Osteoarthritic Cartilage Gene TBC1D14, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DA736264   Gene TBC1D14, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB369868   Gene TBC1D14, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DA737282   Gene TBC1D14, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB236326 trachea Gene TBC1D14, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k, .l, .m, .n-u, .o-u, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C